Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2000 Sep;106(6):733-8.
doi: 10.1172/JCI11144.

Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?

Affiliations

Hypoxia-induced pulmonary vascular remodeling: a model for what human disease?

N F Voelkel et al. J Clin Invest. 2000 Sep.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mechanisms that may be involved in hypoxia-induced pulmonary vascular remodeling. Growth factors for VSMCs can be generated as consequences of elevated shear stress or of oxidant stress and may be dependent or independent of hypoxia-inducible factor 1α (HIF-1α). ROSs may also affect gene expression, activate proteinases, and trigger the production of cytokines.
Figure 2
Figure 2
Pulmonary vascular morphology of vehicle-treated (a) or SU5416-treated (b) rats exposed to Denver altitude conditions for 3 weeks. Note the increase in medial thickness in the SU5416-treated rat lungs, which extends into preacinar vessels (arrow). On the other hand, normal pulmonary arteries have well defined medial muscular layer (arrow), which becomes progressively thinner (dashed arrow) in the preacinar region.
Figure 3
Figure 3
Lungs from chronically hypoxic rats treated with the VEGF-R2 inhibitor SU5416 for 3 weeks. (a) Intimal obliteration of precapillary pulmonary artery (arrows), resulting in almost-complete disappearance of vascular lumen; (b) the intimal obliteration is due to expansion of Factor VIII–related antigen–positive cells (arrow). (c) The intraluminal cluster of endothelial cells shows expression of the key apoptosis effector active caspase 3 (arrowhead), while endothelial cells in the center of the cluster (arrow) show evidence of proliferation with expression of proliferating cell nuclear antigen (inset, arrowheads). (d) Caspase inhibition with the broad spectrum caspase inhibitor Z-Asp-CH2, administered at the beginning of the chronic hypoxia and SU5416 treatment, results in a marked decrease in pulmonary artery pressures. The pulmonary arteries are lined by a monolayer of Factor VIII–related antigen–positive endothelial cells, with preservation of vascular lumen. (a: pentachrome staining, ×320; b: Factor VIII–related antigen immunostaining, ×300; c: active caspase 3 immunostaining, ×400; d: Factor VIII–related antigen immunostaining, ×200.)

References

    1. Will DH, Alexander AF, Reeves JT, Grover RF. High altitude-induced pulmonary hypertension in normal cattle. Circ Res. 1962;10:172–177. - PubMed
    1. Voelkel NF, Wiegers U, Sill V, Trautmann J. Kinetic study on the lung DNA-synthesis stimulated by chronic high altitude hypoxia. Thorax. 1977;32:578–584. - PMC - PubMed
    1. Rabinovitch M, Gamble W, Nadas AS, Miettinen O, Reid L. Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol. 1979;236:H818–H827. - PubMed
    1. Stenmark K, et al. Severe pulmonary hypertension and arterial adventitial changes in newborn calves at 4300 m. J Appl Physiol. 1987;62:821–830. - PubMed
    1. Voelkel NF, Tuder RM, Lepley RA, Fitzpatrick FA. Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats. J Clin Invest. 1996;97:2491–2498. - PMC - PubMed

Publication types

MeSH terms